- Home
- CYRX vs PNNT Comparison
CYRX vs PNNT Comparison
Compare CYRX & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYRX
- PNNT
- Stock Information
- Founded
- CYRX 1999
- PNNT 2007
- Country
- CYRX United States
- PNNT United States
- Employees
- CYRX N/A
- PNNT N/A
- Industry
- CYRX Biotechnology: Pharmaceutical Preparations
- PNNT Finance: Consumer Services
- Sector
- CYRX Health Care
- PNNT Finance
- Exchange
- CYRX Nasdaq
- PNNT Nasdaq
- Market Cap
- CYRX 438.7M
- PNNT 427.7M
- IPO Year
- CYRX N/A
- PNNT 2007
- Fundamental
- Price
- CYRX $9.80
- PNNT $6.46
- Analyst Decision
- CYRX Strong Buy
- PNNT Sell
- Analyst Count
- CYRX 10
- PNNT 5
- Target Price
- CYRX $12.20
- PNNT $6.38
- AVG Volume (30 Days)
- CYRX 573.5K
- PNNT 563.2K
- Earning Date
- CYRX 11-06-2025
- PNNT 11-24-2025
- Dividend Yield
- CYRX N/A
- PNNT 14.86%
- EPS Growth
- CYRX N/A
- PNNT 21.65
- EPS
- CYRX 1.35
- PNNT 0.80
- Revenue
- CYRX $237,879,000.00
- PNNT $130,923,000.00
- Revenue This Year
- CYRX N/A
- PNNT N/A
- Revenue Next Year
- CYRX $9.09
- PNNT N/A
- P/E Ratio
- CYRX $7.26
- PNNT $8.10
- Revenue Growth
- CYRX 24.93
- PNNT N/A
- 52 Week Low
- CYRX $4.58
- PNNT $5.72
- 52 Week High
- CYRX $10.46
- PNNT $7.53
- Technical
- Relative Strength Index (RSI)
- CYRX 56.74
- PNNT 25.83
- Support Level
- CYRX $9.28
- PNNT $6.53
- Resistance Level
- CYRX $9.81
- PNNT $6.80
- Average True Range (ATR)
- CYRX 0.47
- PNNT 0.13
- MACD
- CYRX -0.02
- PNNT -0.02
- Stochastic Oscillator
- CYRX 52.47
- PNNT 5.56
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
About PNNT PennantPark Investment Corporation
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.